Benefit From Fractionated Dose-Dense Chemotherapy in Patients With Poor Prognostic Ovarian Cancer: ICON-8 Trial.

Olivier ColombanAndrew ClampAdrian CookIain A McNeish Benoit You

Published in: JCO clinical cancer informatics (2023)

Fractionated dose-dense chemotherapy might be beneficial for patients belonging to the poor prognostic group characterized by lower tumor chemosensitivity assessed with the online calculator CA-125-Biomarker Kinetics and incomplete debulking surgery. Further investigation in the future SALVOVAR trial is warranted.

Keyphrases

end stage renal disease
study protocol
clinical trial
phase iii
ejection fraction
minimally invasive
chronic kidney disease
social media
prognostic factors
healthcare
brain metastases
patient reported outcomes
current status
squamous cell carcinoma
atrial fibrillation
protein kinase
double blind